Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INCYTE CORPINCY · Entity 3182 | EVP, Head of Incyte Intl | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INCYTE CORP
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,578 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 463 · Balance 37,578 F1: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F2: This includes an aggregate of 26,884 shares of common stock issuable pursuant to previously reported RSUs that have not vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
F2: This includes an aggregate of 26,884 shares of common stock issuable pursuant to previously reported RSUs that have not vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 20:01 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 463 | $117.14 | $54,235.82 |
DisclosureSEC source: 0002039219-26-000010 · wk-form4_1791230516.xml · nonDerivative · entry 1 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,578 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F2 · balance_after: This includes an aggregate of 26,884 shares of common stock issuable pursuant to previously reported RSUs that have not vested. Read SEC document |
| July 23, 2026 Filed Jul 27, 2026 22:23 UTC | INCYTE CORP INCY · Entity 3182 | GrantPerformance Shares · Derivative | 13,498 | $0.00 | $0.00 |
DisclosureSEC source: 0002039219-26-000008 · wk-form4_1785190979.xml · derivative · entry 2 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,498 Underlying: Common Stock · 13,498 shares Expires 2029-07-23 F2 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F2 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| July 23, 2026 Filed Jul 27, 2026 22:23 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 15,423 | $0.00 Strike: $116.69 | $0.00 |
DisclosureSEC source: 0002039219-26-000008 · wk-form4_1785190979.xml · derivative · entry 1 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,423 Underlying: Common Stock · 15,423 shares Expires 2036-07-22 F1 · derivative.exercise_date: The July 23, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:07 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 111 | $102.67 | $11,396.37 |
DisclosureSEC source: 0002039219-26-000004 · wk-form4_1770239219.xml · nonDerivative · entry 1 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,041 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F2 · balance_after: This includes an aggregate of 33,496 shares of common stock issuable pursuant to previously reported RSUs that have not vested. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:07 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 8,911 | $0.00 | $0.00 |
DisclosureSEC source: 0002039219-26-000002 · wk-form4_1769029623.xml · nonDerivative · entry 1 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,152 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Including the January 16, 2026 grant, this includes an aggregate of 35,078 shares of common stock issuable pursuant to previously reported RSUs that have not vested. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:12 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 3,074 | $94.02 | $289,017.48 |
DisclosureSEC source: 0002039219-25-000005 · wk-form4_1762377132.xml · nonDerivative · entry 1 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,241 F1 · balance_after: This includes an aggregate of 26,167 shares of common stock issuable pursuant to previously reported RSUs that have not vested. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:02 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 463 | $86.70 | $40,142.10 |
DisclosureSEC source: 0002039219-25-000003 · wk-form4_1759521738.xml · nonDerivative · entry 1 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,315 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F2 · balance_after: This includes an aggregate of 26,167 shares of common stock issuable pursuant to previously reported RSUs that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:02 UTC | INCYTE CORP INCY · Entity 3182 | GrantPerformance Shares · Derivative | 6,577 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000088 · wk-form4_1752782572.xml · derivative · entry 1 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,577 Underlying: Common Stock · 6,577 shares Expires 2028-07-15 F1 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F1 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 21:32 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 6,331 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000044 · wk-form4_1738618351.xml · nonDerivative · entry 1 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,778 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Including the January 31, 2025 grant, this includes an aggregate of 32,778 shares of common stock issuable pursuant to previously reported RSUs that have not vested. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 17:28 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 26,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-24-000163 · wk-form4_1727976482.xml · nonDerivative · entry 1 Heeson Lee · CIK 0002039219 · EVP, Head of Incyte Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,447 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Including the October 1, 2024 grant, this includes an aggregate of 26,447 shares of common stock issuable pursuant to previously reported RSUs that have not vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.